Ranbaxy Laboratories Ltd, India’s top drugmaker by sales, said its Moroccan unit has started functioning, giving it direct access to a $1 billion pharmaceuticals market. The unit, Ranbaxy’s third in Africa, will also help the company supply products to other north African countries in future, it said on Monday. Ranbaxy’s Africa sales rose 23 per cent to $189 million in 2011, it had said last month. The drugmaker, majority owned by Japan’s Daiichi Sankyo, has sales staff of about 1,000 in 44 African countries and makes drugs in Nigeria and South Africa.
GMT 22:53 2018 Thursday ,13 December
Indian Minister of Trade meets with UAE Ambassador, Chairman of Emaar PropertiesGMT 13:41 2018 Thursday ,06 December
Tyre maker Continental opens lab to extract rubber from dandelionsGMT 15:22 2018 Friday ,30 November
Paper industry around famous Chinese lake to be shut down by 2019GMT 11:13 2018 Sunday ,18 November
Electricx 2018 kicks off with participation of over 20 countriesGMT 14:17 2018 Thursday ,25 October
BP eyes entering several new Rosneft projectsGMT 12:08 2018 Saturday ,20 October
OPEC participants performed Vienna Agreement by 111%GMT 16:14 2018 Saturday ,06 October
Saudi Aramco IPO to go ahead by early 2021GMT 19:01 2018 Thursday ,04 October
LEAD S. Korean firms offer aid for quake-hit IndonesiaMaintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2021 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2021 ©
Send your comments
Your comment as a visitor